Breast pathology is the subspecialty of Pathology dealing with diseases of the breast, both benign and malignant. This area also includes evaluation of axillary lymph nodes.
 |
 |
Allison H.S. Hall, MD, PhD (919-613-7399) is a surgical pathologist with expertise in women’s pathology, including breast and gynecologic pathology. Her research interests include progression from pre-malignant lesions to invasive breast cancer, pathogenesis of ovarian carcinoma, HPV-related disease of the female genital tract, and global women’s health.
Sarah Bean, MD (919-681-6413) is a Cytopathologist and Breast and Gynecologic Surgical Pathologist who specializes in women's health care. Since 2006, she has provided excellent patient care at Duke. She is also a passionate medical educator, involved in graduate medical education (GME) and continuing medical education (CME). Her current scholarly interests include human papillomavirus (HPV), p16, GME, feedback, competence, milestones, professionalism and generational differences in learners.
Rex Bentley, MD (919-684-6423) is known for his expertise in breast cancer. His research interests include minimally invasive biopsy techniques such as image guided core needle biopsies, and the correlation of pathologic results with mammographic findings. Dr. Bentley is also an expert in gynecologic pathology, and has ongoing collaborations with several research laboratories engaged in translational research on breast cancer.
Raj C. Dash, MD (919-668-3352) is a board certified pathologist with fellowship training in Cytopathology and Informatics. He currently serves as the Beaker physician champion and Director for Laboratory Informatics Strategy. He has an undergraduate degree in computer science and specializes in medical informatics, fine needle aspiration cytology and surgical pathology of breast cancer. Dr. Dash is active on a number of national committees serving the College of American Pathologists, including the Informatics Committee (serving as chair).
Edgardo R. Parrilla Castellar, MD, PhD (919-681-6983) is a leading breast cancer diagnostician at Duke’s Department of Pathology and is Associate Medical Director of Duke’s Clinical Molecular Diagnostic Laboratory, where he hopes to leverage his skills in oncologic molecular genetics for personalized cancer care. His current research efforts focus on innovative, non-invasive approaches for the detection and diagnosis of breast cancer, with ultimate goal of distinguishing biologically aggressive tumors for targeted chemo-/immunotherapy. Following his MD-PhD degree, Dr. Parrilla completed Anatomic Pathology residency at the National Institutes of Health and fellowships in Selective Surgical Pathology and Molecular Genetic Pathology at Mayo Clinic prior to joining Duke. He is board-certified in Anatomic Pathology and Molecular Genetic Pathology.
